Amalgam’s Scalable Digital Platform Powers the Mobile App for Biolinq Shine™, an FDA De Novo–Cleared, Needle-Free Glucose SensorWILMINGTON, Del.--(BUSINESS WIRE)--#clinical--Amalgam…
$750,000 grant will accelerate the development of a point-of-care diagnostic to improve maternal health outcomes in low-resource settings SEATTLE, Oct.…
Initial target markets for commercialization include Germany, the Benelux countries, Austria, the United Kingdom, and Scandinavia Expands distributor channel coverage…
NEW YORK, Oct. 9, 2025 /PRNewswire/ -- The Wearable Medical Devices Market is poised for remarkable expansion, projected to surge from…
BERKELEY, Calif, Oct. 07, 2025 (GLOBE NEWSWIRE) -- Profusa, Inc. (“Profusa” or the “Company”) (Nasdaq: PFSA), a commercial stage digital…
MELBOURNE, Australia, Oct. 2, 2025 /PRNewswire/ -- Diagnostics company Nutromics has presented the world's first real-time, continuous data on two…
Pioneering Dual-Use Technology Company Will Lead World-Class Team to Develop and Deploy Real-Time Biosensors, Risk Assessment Software, and Automated Building…
Pr. Yann Gouëffic and affiliates (FRANCE-PAD) cover ~8% of all CLTI cases in France BERKELEY, Calif, Oct. 01, 2025 (GLOBE…
First glucose sensor with an integrated primary display that works with and without a phone Establishes a new category of…
MarketNewsUpdates News Commentary NEW YORK, Sept. 11, 2025 /PRNewswire/ -- The global Diagnostic Biomarker market is experiencing unprecedented growth and…